An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).
PHASE2CompletedINTERVENTIONAL
Enrollment
91
Participants
Timeline
Start Date
March 31, 2007
Primary Completion Date
June 30, 2008
Study Completion Date
June 30, 2008
Conditions
Postherpetic NeuralgiaNeuralgiaHerpes Zoster
Interventions
DRUG
placebo
twice daily for 4 weeks
DRUG
carisbamate
200 mg tablet twice daily for 4 weeks
All Listed Sponsors
lead
SK Life Science, Inc.
INDUSTRY
NCT00492323 - An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN). | Biotech Hunter | Biotech Hunter